CADL EBITDA Margin
Candel Therapeutics Inc · EBITDA Margin
CADL EBITDA Margin
Latest reported-103519.35%period ending
CADL TTM EBITDA Margin (-11064.52% → -103519.35%)
TTM ebitda margin
High-resolution chart · PNG
CADL ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -103,519.3548% | |
| -52,474.1935% | |
| -29,383.871% | |
| -22,735.4839% | |
| -22,479.0323% | |
| -29,073.3871% | |
| -30,498.3871% | |
| -27,119.3548% | |
| -25,955.6452% | |
| -15,119.3548% | |
| -12,955.6452% | |
| -11,064.5161% |